Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05467085 · ClinicalTrials.gov registry record · NA

Imaging-Guided Low Intensity Focused Ultrasound (LIFU)

A NA study of Obsessive - Compulsive Disorder, sponsored by Baylor College of Medicine.

Active
Registry status
NA
Development phase
20
Enrollment target
3
Study locations

NCT05467085 is a NA study of Obsessive - Compulsive Disorder that is active but no longer recruiting, run by Baylor College of Medicine. The registered enrollment target is 20 participants, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05467085, a NA study of Obsessive - Compulsive Disorder, is active but no longer recruiting, sponsored by Baylor College of Medicine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
3
Study locations

Study Summary

This research study is to investigate the safety, feasibility, and possible therapeutic benefits of a technology called Low Intensity Focused Ultrasound (LIFU) in patients with obsessive- compulsive disorder (OCD). The device used in this study transmits high frequency sound waves to a particular region of the brain called the Ventral Striatum (VS). LIFU is a non-invasive form of stimulation, which can be used to stimulate deep regions of the brain. In this study, the investigators will administer LIFU to activate the VS area of the brain while also observing this brain stimulation with an MRI machine. Other aims of this study include learning more about the patterns of brain activity associated with OCD and seeing if brain activity changes as symptoms of OCD change over time during the two weeks of LIFU stimulation. Participants in this study will be asked to perform computer administered behavioral tasks -- similar to simple computer games -- to examine whether certain features of OCD (e.g., avoidance of feared triggers) change over the course of LIFU stimulation. The treatment phase of this research study is expected to last two weeks with three weekly (total of 6) treatment sessions all carried at the MRI brain imaging center at Baylor College of Medicine. There will be at least one additional screening visit before treatment starts and a series of follow up visits over a six-month period.

Interventions

  • DEVICE BX Pulsar 1002

Study Locations (3)

Texas

  • Baylor College of Medicine - Houston
  • MD Anderson - Houston

Massachusetts

  • Massachussetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-08-01
Est. Completion 2026-08-01
Phase NA

Sponsor

Baylor College of Medicine

616 total trials

What the Registry Record Tells You About NCT05467085

The ClinicalTrials.gov registry entry for NCT05467085 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (99% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 1 intervention - of which BX Pulsar 1002 is the first listed.

NCT05467085 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Texas, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05467085 about?

NCT05467085 is a clinical study titled "Imaging-Guided Low Intensity Focused Ultrasound (LIFU)". This research study is to investigate the safety, feasibility, and possible therapeutic benefits of a technology called Low Intensity Focused Ultrasound (LIFU) in patients with obsessive- compulsive disorder (OCD). The device used in this study transmits high frequency sound waves to a particular re...

What is the current status of trial NCT05467085?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-08-01. Estimated completion is 2026-08-01.

What conditions does trial NCT05467085 study?

This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.

What interventions are being tested in trial NCT05467085?

The interventions under investigation include: BX Pulsar 1002 (DEVICE).

Who is sponsoring clinical trial NCT05467085?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05467085 being conducted?

This trial has 3 study locations across Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obsessive - Compulsive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.